The FDA cannot accept any new funding during the shutdown, now in its 28th day, forcing the agency to stretch its remaining money to last only about five more weeks. » Read More
By: Angelica LaVito
The FDA says doctors need more information about treating kids for nicotine use since most cessation products are only for adults. » Read More |
By: Angelica LaVito
The FDA's change clears the way for drugmakers to sell naloxone without a prescription. The life-saving treatment for opioids is also known as Narcan and Evzio. » Read More |
By: Elizabeth Gurdus
Jim Cramer breaks down the potential behind struggling shipping giant UPS. » Read More |
Jim Cramer explains why there's been more merger and acquisition activity in recent months and says it's "just getting started."
Americans are more likely to die from an accidental opioid overdose today than from a car crash, according to a study released Monday from the National Safety Council.
UnitedHealth Group kicks off earnings season for the health care sector Tuesday morning, and analysts are expecting double-digit sales and profit growth from the nation's largest health insurance and health care services firm.
Canopy Growth has been granted a license by New York State to process and produce hemp.
AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Biotech's having a huge run, but one technician is warning about the sector.
Privateer Holdings says it "strongly believes in Tilray's long-term global growth strategy and pioneering role" in legal cannabis.
While the numbers are milder than last season, the CDC's "influenza like illness level" last week was elevated at 4.1 percent, almost twice national baseline.
Two new deals to start the year and positive trial presentations at the J.P. Morgan Health Care conference have breathed new life into some of last year's biggest stock losers.
The bills, led by Sanders and Reps. Elijah Cummings and Ro Khanna, would permit Health and Human Services Secretary Alex Azar to negotiate lower prices for drugs under Medicare Part D, the federal program for prescription drug benefits.
Star investor Jeff Vinik, who just announced the revival of his hedge fund, doesn't see any money in cannabis stocks.
Researchers have developed a smartphone app that can detect an opioid overdose. Called Second Chance, the app accurately detects overdose-related symptoms by monitoring breathing patterns, then sends an alert so Narcan can be administered in time.
Canopy Growth shares surged 13 percent after Piper Jaffray initiates coverage of the cannabis industry, joining a growing list of brokerages watching the space.
Jim Cramer explains why renewed strength in the retail and housing stocks could make the Fed rethink the rate hike pause.
FDA Commissioner Scott Gottlieb's keynote address Tuesday was delivered via video conference from Washington, D.C., to thousands of bankers and health executives, and his audio cut out just as he was making a key point on teen nicotine use.
The National Cannabis Industry Association counters by saying: "So far, there is nothing to suggest that cannabis consumption causes mental illness."
Get the best of CNBC in your inbox
Data also provided by 
